Neutron treatment for squamous cell carcinoma SIR,-Dr Mary Catterall's letter' cannot stand unchallenged. Firstly, it is quite possible to cure some advanced head and neck cancers without incurring great tissue damage to the degree which resulted from neutron treatment as described by Mr N Stafford and colleagues.2 Secondly, it is almost beyond belief that Dr Catterall seriously compares the advent of neutron treatment with the quantum leap that was made when effective chemotherapy for Hodgkin's disease was first used. This particular example represents one of the very few instances in modern cancer therapy where the magnitude of the advance was so great that no one could have countenanced a randomised controlled study in patients with advanced disease, for which no War and medicine SIR,-As practising hospital and primary care doctors we are concerned that an excess of postwar euphoria is denying the British people adequate information on the true state of defeated Iraq. We cannot know the facts, but if the widely quoted figure of 100 000 dead in the Iraqi army is correct the allied forces have exterminated the equivalent of the entire population of a medium sized English town, probably-in view of the Iraqi soldiers' actual morale and degree of disaffection-gratuitously, even in military terms.
The eventual civilian death toll from wartime allied air bombardment, the probable epidemics of gastroenteritis and hepatitis, air pollution, food and fresh water shortages, and the destruction of hospitals in Baghdad and Basra may in a short time double this total. Many will have perished in a "turkey shoot" by unopposed allied air attack after Iraq had signalled its desire to comply and withdraw. Those wounded or suffering non-fatal illness will further increase the medical need, which will also include the care of many children who will die prematurely. Rather than utilise resources to tackle famine and disease in Africa, the Western powers have chosen to expend enormous monies on a second killing field in the Arab world in aid of the restoration in Kuwait of a regime bereft of democracy and with a poor record on human rights. Some war, some victory.
This takes place against the continuing decline of the British NHS with which readers of this journal will all be familiar and for which we are repeatedly and inaccurately told there are no funds available. The Supply of blood products SIR, -In October 1990 the Department of Health issued a statement entitled Supply ofblood products: the UK view. It read: "Since 1976 it has been government policy that the UK with its long tradition of voluntary blood donation should be self-sufficient in blood products. This position is entirely consistent with the more recent decision by the EC to promote a policy of community self-sufficiency based on voluntary blood donation.
"At the same time, Ministers accord great importance to the principle of clinical freedom. Where therefore a doctor decides, in the light of the available clinical information, that a particular product is indicated for a particular patient, we believe that this decision should be respected even if that product has to be imported from outside the EC. The principle of self-sufficiency therefore means that the supplies of domestically sourced blood products should be sufficient, both in range and quantity, to meet the needs of all patients whose clinicians prefer these to other available products." For many in the blood transfusion services this statement will be profoundly disappointing. It fails to deal with the central issue that led to the recent European Commission directive-concern about the heightened potential hazard of virus transmission to patients when blood products are derived from paid donors.' The department's use of the word voluntary without including the word unpaid is both unhelpful and misleading. The promotion of national and European self sufficiency in blood and blood products is linked by the EC with the promotion of safety: by inference those countries that have to resort to importing blood products derived from paid donors will have failed to meet EC standards.
The second paragraph of the department's statement seems to give greater importance to promoting clinical freedom than product safety, placing a substantial burden on to the shoulders of prescribing clinicians, health authorities, and the Medicines Control Authority. These burdens could have unwelcome legal and financial consequences.
The government has already committed capital to both British plasma fractionation centres. But if we must now link clinical freedom with the promotion of self sufficiency based on the unpaid donor then the government needs to look beyond investment in property and equipment. The blood transfusion services need more effective integration and management. Beyond this there is a need for enhanced investment in research directed towards developing blood based products that meet the needs of prescribers such as coagulation factor concentrates derived from unpaid British donors.
Finally, the government ought to persuade its Medicines Control Authority to restrict the licensing and importation of blood products derived from paid donors and take on board the pharmaceutical industry's guidelines concerned with the quality of information required in claims about superiority of products.2 Exhortations on the sanctity of clinical freedom in the context of self sufficiency of blood products are wholly inappropriate. They facilitate the continual movement of operational goalposts and frustrate those who are working-with public money and plasma from British donors-to secure national self sufficiency in blood and blood products.
We (and, we suspect, the EC) would have much preferred the Department of Health's statement to have read: "The principle of self-sufficiency in the UK means that the supplies of domestically sourced blood products will be sufficient, both in range, quantity, and quality, to meet the needs of all patients. Where this is not possible, preference should be given to sources using unpaid donors, and audit arrangements put in place designed to ascertain why such external supply arrangements are necessary and whether they need to be sustained." 
